SavedAdd your journal

Journals / Nöropsikiyatri Arşivi / 2014 / Cilt: 51 - Sayı: 1

Risk factors for diabetic polyneuropathy

Diyabetik polinöropati için risk faktörleri

Yüksel KAPLAN
SEMİHA GÜLSÜM KURT
Hatice ÜNALDI KARAER
ÜNAL ERKORKMAZ
Pages
11–14
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The association of neuropathy with retinopathy and hypertension is important.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Introduction: The aim of this study was to investigate the risk factors for distal symmetric sensory-motor polyneuropathy (DSP) in patients with type 2 diabetes mellitus (DM).
📊
Key Findings & Data:Met­hods: Sixty seven patients with type 2 DM (33 males and 34 females) were included in the study.
💡
Conclusion & Impact:The association of neuropathy with retinopathy and hypertension is important.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Introduction: The aim of this study was to investigate the risk factors for distal symmetric sensory-motor polyneuropathy (DSP) in patients with type 2 diabetes mellitus (DM). Met­hods: Sixty seven patients with type 2 DM (33 males and 34 females) were included in the study. In addition to a detailed neurological examination, the Michigan Neuropathy Screening Instrument was administered to all patients and their total neuropathy scores were calculated. Nerve conduction examinations were performed for all patients. Re­sults: The mean age of the patients was 52.83±.87 years. The mean glycosylated hemoglobin (HbA1C) value was 8.56±2.07% (normal: 3-6.5%). The total neuropathy score significantly correlated with diabetes duration, hypertension, retinopathy, and HbA1C. Conc­lu­si­on: This study confirms the previous reports regarding the association of neuropathy with poor glycaemic control and duration of the disease. The association of neuropathy with retinopathy and hypertension is important.

Özet

Giriş: Bu çalışmada tip 2 diyabetes mellituslu (DM) hastalarda distal simetrik sensori-motor polinöropati (DSP) için risk faktörlerinin araştırılması amaçlanmıştır. Yön­tem­: Tip 2 DM olan 34’ü kadın, 33’ü erkek olmak üzere 67 hasta çalışmaya alındı. Hastaların ayrıntılı nörolojik muayeneleri yapılıp, Michigan Nöropati Değerlendirme Ölçeği’nin Nöropati Tarama Anketi uygulandı ve total nöropati skorları hesaplandı. Polinöropati protokolüne uygun olarak sinir iletim çalışmaları yapıldı. Bul­gu­lar: Hastalar 32-77 yaş arasındaydı ve yaş ortalamaları 54,57±8,64 idi. Ortalama glikolize hemoglobin (HbA1C) değerleri %8,32±1,81 (normal: %3-6,5) idi. Total nöropati skoru, diyabet süresi, nöropatik semptom süresi, hipertansiyon, retinopati ve HbA1C değerleri arasında istatistiksel olarak anlamlı ilişki saptandı. So­nuç: Bu çalışma DSP ile DM süresi ve kötü glisemik kontrol arasındaki ilişkiyi bildiren diğer çalışmaları doğrulamaktadır. Nöropati ile retinopati ve hipertansiyon arasında saptanan ilişki de önemlidir.

🔖

Cite This Article

KAPLAN, Y., KURT, S. G., KARAER, H. Ü., ERKORKMAZ, Ü. (2014). Risk factors for diabetic polyneuropathy. Nöropsikiyatri Arşivi, Cilt: 51 - Sayı: 1, 11–14. https://ajindex.com/articles/294401

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Ertekin C. Diyabetik nöropatiler. Ertekin C, editör. Sentral ve periferik EMG içinde
  2. Baskı. İzmir: Meta Basım; 2006; s.212-213
  3. Vileikyte L, Leventhal H, Gonzalez JS, Peyrot M, Rubin RR, Ulbrecht JS, Garrow A, Waterman C, Cavanagh PR, Boulton AJ. Diabetic peripheral neuropathy and depressive symptoms: the association revisited. Diabetes Care 2005; 28:2378-2383
  4. Maser R, Steenkiste A, Dorman J, Nielsen V, Bass E, Manjoo Q, Drash AL, Becker DJ, Kuller LH, Greene DA. Epidemiological correlates of diabetic neuropathy: report from Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes 1989; 38:1456-1461
  5. Tesfaye S, Stevens L, Stephenson J, Fuller J, Plater M, Ionescu- Tirgoviste C, Nuber A, Pozz G, Ward JD. Prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential risk factors: the EURODIAB Type I Complications Study. Diabetologia 1996; 39:1377-1384
  6. Forrest K, Maser R, Pambianco G, Becker D, Orchard T. Hypertension as a risk factor for diabetic neuropathy: a prospective study. Diabetes 1997; 46:665-670
  7. Adler AI, Boyko EJ, Ahroni JH, Stensel V, Forsberg RC, Smith DG. Risk factors for diabetic peripheral sensory neuropathy. Results of the Seattle Prospective Diabetic Foot Study. Diabetes Care 1997; 20: 1162-1167
  8. Tkac I, Bril V: Glycemic control is related to the electrophysiologic severity of diabetic peripheral sensorimotor polyneuropathy. Diabetes Care 1998; 21:1749-1752
  9. Barbosa AP, Medina JL, Ramos EP, Barros HP, The DPN in Porto Study Group. Prevalence and risk factors of clinical diabetic polyneuropathy in a Portuguese primary health care population. Diabetes Metab 2001; 27:496-502
  10. Tamer A, Yıldız S, Yıldız N, Kanat M, Gunduz H, Tahtacı M, Celebi H. The prevalence of neuropathy and relationship with risk factors in diabetic patients: a single-center experience. Med Princ Pract. 2006; 15:190-194
  11. American Diabetes Association. Position statement: standards of medical care for patients with diabetes mellitus. Diabetes Care 2002; 25:33-49
  12. Feldman EL, Stevens MJ. Clinical testing in diabetic peripheral neuropathy. Can J Neurol Sci 1994; 21:3-7
  13. Cornblath DR, Chaudhry V, Carter K,, Lee D, Seysedadr M, Miernicki M, Joh T. Total neuropathy score: validation and reliability study. Neurology 1999; 53:1660-1664
  14. Oh S. Anatomical guide for common nerve conduction studies. Oh Shin MD, editör. Clinical Electromyography: Nerve Conduction Studies içinde
  15. Baskı. Baltim